NASDAQ:MORF • US61775R1059
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MORPHIC HOLDING INC (MORF).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-07-26 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-07-22 | Stifel | Maintains | Hold -> Hold |
| 2024-07-09 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-07-09 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2024-07-09 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-03-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-12-08 | Citigroup | Initiate | Buy |
| 2023-09-28 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-09-25 | BTIG | Downgrade | Buy -> Neutral |
| 2023-09-25 | Stifel | Maintains | Hold -> Hold |
| 2023-08-09 | Stifel | Downgrade | Buy -> Hold |
| 2023-07-21 | Berenberg | Initiate | Buy |
| 2023-04-26 | BMO Capital | Maintains | Outperform |
| 2023-04-26 | RBC Capital | Maintains | Outperform |
| 2023-04-25 | Wells Fargo | Maintains | Overweight |
| 2023-03-08 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | Wells Fargo | Maintains | Overweight |
| 2022-11-03 | RBC Capital | Maintains | Outperform |
| 2022-09-07 | Stifel | Initiate | Buy |
| 2022-08-04 | RBC Capital | Maintains | Outperform |
| 2022-08-04 | Wells Fargo | Maintains | Overweight |
| 2022-07-20 | SVB Leerink | Initiate | Outperform |
| 2022-05-05 | Wells Fargo | Maintains | Overweight |
| 2022-02-25 | RBC Capital | Maintains | Outperform |
| 2022-02-11 | BTIG | Initiate | Buy |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.79M -55.97% | 70.81M 257.81% | 521K -99.26% | 255K -51.06% | 291.424K 14.28% | 408K 40.00% | 1.224M 200.00% | 156.53M 12,688.40% | 381.13M 143.49% | 865.28M 127.03% | 1.204B 39.15% | |
| EBITDA YoY % growth | -94.78M -105.82% | -62.39M 34.17% | -177.595M -184.65% | -233.781M -31.64% | -278.027M -18.93% | -320.55M -15.29% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -95.81M -103.07% | -63.4M 33.83% | -178.686M -181.84% | -228.702M -27.99% | -248.559M -8.68% | -272.201M -9.51% | -312.28M -14.72% | -226.393M 27.50% | -128.856M 43.08% | 186.04M 244.38% | 602.07M 223.62% | |
| Operating Margin | -484.13% | -89.54% | -34,296.74% | -89,687.11% | -85,291.25% | -66,715.96% | -25,513.06% | -144.63% | -33.81% | 21.50% | 50.01% | |
| EPS YoY % growth | -2.67 -81.63% | -1.59 40.45% | -3.51 -120.75% | -4.07 -16.05% | -4.33 -6.36% | -4.52 -4.30% | -5.07 -12.28% | -3.49 31.20% | -1.16 66.83% | 5.90 609.54% | 6.91 17.15% |
All data in USD
| Q3 / 24 | Q4 / 24 | |
|---|---|---|
| EPS Q2Q % growth | -1.03 -41.12% | -1.10 -14.75% |
| Revenue Q2Q % growth | 72.859K | 218.576K |
| EBITDA Q2Q % growth | -60.119M -36.82% | -63.931M -32.25% |
| EBIT Q2Q % growth | -58.681M -31.13% | -59.563M -20.50% |
All data in USD
15 analysts have analysed MORF and the average price target is 59.6 USD. This implies a price increase of 4.57% is expected in the next year compared to the current price of 56.99.
MORPHIC HOLDING INC (MORF) will report earnings on 2024-11-01, before the market open.
The consensus EPS estimate for the next earnings of MORPHIC HOLDING INC (MORF) is -1.03 USD and the consensus revenue estimate is 72.86K USD.
The consensus rating for MORPHIC HOLDING INC (MORF) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.